GRCE earnings
Grace Therapeutics (GRCE) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
- GRCE reports next on Feb 15, 2027, with EPS of -0.15 expected.
- GRCE beat EPS estimates in 10 of its last 16 reports.
GRCE earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2027 | Nov 12, 2026 | -0.11 | -0.15 | 26.67% | – |
| Q1 2027 | Aug 13, 2026 | -0.91 | -0.13 | -603.79% | – |
| Q4 2026 | Jun 18, 2026 | -0.07 | -0.24 | 70.83% | – |
| Q3 2026 | Feb 12, 2026 | -0.14 | -0.09 | -55.56% | – |
| Q2 2026 | Nov 13, 2025 | -0.08 | -0.12 | 31.50% | – |
| Q1 2026 | Aug 12, 2025 | -0.21 | -0.22 | 4.55% | – |
| Q4 2025 | Jun 23, 2025 | 0.10 | -0.20 | 150.00% | – |
| Q3 2025 | Feb 13, 2025 | -0.26 | -0.24 | -8.33% | – |
| Q2 2025 | Nov 13, 2024 | -0.33 | -0.33 | 0.00% | – |
| Q1 2025 | Aug 9, 2024 | -0.24 | -0.27 | 9.43% | – |
| Q4 2024 | Jun 21, 2024 | -0.17 | -0.35 | 51.43% | – |
| Q3 2024 | Feb 12, 2024 | -0.21 | -0.23 | 8.70% | – |
| Q2 2024 | Nov 13, 2023 | -0.43 | -0.26 | -65.38% | – |
| Q1 2024 | Aug 11, 2023 | -0.54 | -0.28 | -92.86% | – |
| Q4 2023 | Jun 23, 2023 | -3.90 | -0.84 | -364.29% | – |
| Q3 2023 | Feb 14, 2023 | -0.54 | -0.74 | 27.03% | – |
| Q2 2023 | Nov 14, 2022 | -0.66 | – | – | – |